ProQR Therapeutics
Price & Volume
Stats
See moreOpen | $2.49 |
Previous Close | $2.50 |
Day Range | $2.39-$2.55 |
52W Range | $1.07-$4.62 |
Market Cap | $263.3M |
Shares Short | 1M |
Financials
See moreRevenue (12 Mos) | $17.1M |
Revenue Growth (YoY) | -38.5% |
Gross Profit (12 Mos) | $17.1M |
Diluted EPS | -$0.47 |
News
See moreYahoo Finance • 2 months ago
ProQR Announces Second Quarter 2025 Operating and Financial Results
Yahoo Finance • 3 months ago
ProQR Therapeutics' SWOT analysis: RNA editing pioneer's stock faces clinical hurdles
Yahoo Finance • 3 months ago
ProQR stock advances as JMP reiterates bullish stance on RNA editing
Yahoo Finance • 4 months ago
ProQR submits clinical trial application for RNA editing therapy
About
CEO | Mr. Daniel Anton de Boer |
Address | Zernikedreef 9, Leiden, Netherlands, 2333 CK |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 166 |
